HomeCompareSLGCW vs XYLD

SLGCW vs XYLD: Dividend Comparison 2026

SLGCW yields 2325.58% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLGCW wins by $40776875559.50M in total portfolio value
10 years
SLGCW
SLGCW
● Live price
2325.58%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40776875559.52M
Annual income
$37,596,667,161,556,740.00
Full SLGCW calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — SLGCW vs XYLD

📍 SLGCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLGCWXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLGCW + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLGCW pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLGCW
Annual income on $10K today (after 15% tax)
$197,674.42/yr
After 10yr DRIP, annual income (after tax)
$31,957,167,087,323,224.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, SLGCW beats the other by $31,957,167,087,320,490.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLGCW + XYLD for your $10,000?

SLGCW: 50%XYLD: 50%
100% XYLD50/50100% SLGCW
Portfolio after 10yr
$20388437779.77M
Annual income
$18,798,333,580,779,976.00/yr
Blended yield
92.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SLGCW right now

SLGCW
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Altman Z
2.1
Piotroski
2/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLGCW buys
0
XYLD buys
0
No recent congressional trades found for SLGCW or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLGCWXYLD
Forward yield2325.58%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$40776875559.52M$25.3K
Annual income after 10y$37,596,667,161,556,740.00$3,219.02
Total dividends collected$40553604915.26M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SLGCW vs XYLD ($10,000, DRIP)

YearSLGCW PortfolioSLGCW Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$243,258$232,558.14$10,818$1,098.39+$232.4KSLGCW
2$5,547,357$5,287,071.06$11,738$1,222.51+$5.54MSLGCW
3$118,616,525$112,680,853.02$12,774$1,364.64+$118.60MSLGCW
4$2,378,696,839$2,251,777,157.33$13,944$1,527.86+$2378.68MSLGCW
5$44,747,448,169$42,202,242,550.89$15,270$1,715.87+$44747.43MSLGCW
6$789,840,516,324$741,960,746,783.42$16,775$1,933.09+$789840.50MSLGCW
7$13,084,759,261,953$12,239,629,909,486.39$18,490$2,184.87+$13084759.24MSLGCW
8$203,501,400,619,673$189,500,708,209,383.28$20,450$2,477.63+$203501400.60MSLGCW
9$2,972,157,381,276,708$2,754,410,882,613,657.00$22,697$2,819.19+$2972157381.25MSLGCW
10$40,776,875,559,522,820$37,596,667,161,556,740.00$25,280$3,219.02+$40776875559.50MSLGCW

SLGCW vs XYLD: Complete Analysis 2026

SLGCWStock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

Full SLGCW Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this SLGCW vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLGCW vs SCHDSLGCW vs JEPISLGCW vs OSLGCW vs KOSLGCW vs MAINSLGCW vs QYLDSLGCW vs JEPQSLGCW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.